经导管瓣膜置换术中术者辐射暴露:心脏外科医生需知
本研究比较了经股动脉(TF)与替代入路(AA)行经导管主动脉瓣置换术时术者的辐射暴露,并评估了杂交手术室与导管室及一次性屏蔽的效果。结果显示AA入路辐射最高,杂交手术室暴露高于导管室,RADPAD未降低暴露。
要点
- AA入路TAVR术者辐射暴露中位数15.1 mRad,显著高于TF的5.5 mRad。
- 杂交手术室行TF-TAVR辐射暴露高于导管室,尽管透视时间无差异。
- 一次性辐射屏蔽垫(RADPAD)未降低术者辐射暴露。
核心结论
- 杂交手术室手术与术者辐射暴露更高相关,AA入路病例辐射最高,RADPAD未减弱暴露,杂交手术室屏蔽需审视。
研究设计与样本
- 前瞻性随机双盲研究,纳入TAVR-TF 50例和TAVR-AA 31例,术者佩戴剂量计,RADPAD或安慰剂随机添加。
主要发现
- TAVR-AA团队辐射暴露中位数15.1 mRad(IQR 8.6,32.4),高于TAVR-TF的5.5 mRad(IQR 2.4,9.8),P<.001。
- TAVR-TF在杂交手术室辐射暴露中位数9.0 mRad(IQR 4.5,11.9),高于导管室的2.2 mRad(IQR 1.3,2.8),P<.001。
- TAVR-TF透视时间在杂交手术室与导管室无差异(20.3±7.4 min vs 19.0±6.4 min,P=.55)。
- RADPAD组辐射暴露中位数9.0 mRad(IQR 4.5,14.7),安慰剂组9.4 mRad(IQR 2.8,19.5),P=.82。
临床怎么用
- 心脏外科医生在杂交手术室行经导管瓣膜置换时应加强辐射防护,AA入路尤其需注意。
- 不应依赖一次性辐射屏蔽垫降低术者辐射暴露。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve replacement expose operators to radiation. These procedures differ primarily in whether they are performed via a transfemoral (TF) or an alternative access (AA) approach. This study compared operator radiation exposure during transcatheter valve implantation when performed via a TF vs an AA approach, when performed in a catheterization lab vs a hybrid operating room (OR), and investigated the potential benefit of disposable shielding. METHODS: Dosimeters were worn during TAVR-TF (n = 50) and TAVR-AA (n = 31) procedures by operators. All TAVR-AA procedures were performed in a hybrid OR and TF procedures were performed in either catheterization labs (n = 16) or a hybrid OR (n = 34). Disposable radiation shielding pads (RADPAD; Worldwide Innovations and Technologies, Inc, Kansas City) or a placebo were added in a randomized, blinded fashion. RESULTS: Team radiation exposure was higher after TAVR-AA vs TAVR-TF (median 15.1 mRad [interquartile range: IQR 8.6, 32.4] vs 5.5 mRad [IQR 2.4, 9.8], P < .001). TAVR-TF procedures required the same amount of fluoroscopy time regardless of where they were performed (20.3 ± 7.4 min in hybrid OR vs 19.0 ± 6.4 min in catheterization lab, P = .55). However, radiation exposure for TAVR-TF remained higher when performed in a hybrid OR (median 9.0 mRad [IQR 4.5, 11.9] vs 2.2 mRad [IQR 1.3, 2.8], P < .001). Radiation exposure was greatest for TAVR-AA (median 15.1 mRad [IQR 8.6, 32.4]). The use of RADPAD did not decrease radiation exposure (median 9.0 mRad [IQR 4.5, 14.7] vs 9.4 mRad [IQR 2.8, 19.5], P = .82). CONCLUSIONS: Procedures performed in the hybrid OR were associated with higher operator radiation exposure. In comparison with the TF approach, AA cases had the highest levels of operator radiation. This is particularly important in cases of transcatheter mitral valve replacement that can only be done via an AA approach. The use of disposable radiation shielding in this series did not attenuate operator radiation exposure. Radiation shielding within hybrid ORs should be scrutinized in an effort to remain on par with that found within catheterization labs.
引用
- Aquino A, Khiabani AJ, Henn MC, et al. Radiation Exposure During Transcatheter Valve Replacement: What Cardiac Surgeons Need to Know. Ann Thorac Surg. 2019. PMID: 31288016. doi:10.1016/j.athoracsur.2019.05.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。